Genetic analysis of heterogeneous subsets of circulating tumour cells from high grade serous ovarian carcinoma patients

  • Pantel, K. & Alix-Panabières, C. Liquid biopsy and minimal residual disease—Latest advances and implications for cure. Nat. Rev. Clin. Oncol. 16(7), 409–424. doi.org/10.1038/s41571-019-0187-3 (2019).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Pantel, K. & Brakenhoff, R. H. Dissecting the metastatic cascade. Nat. Rev. Cancer 4, 448–456 (2004).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Scher, H. I. et al. Phenotypic heterogeneity of circulating tumor cells informs clinical decisions between AR signaling inhibitors and taxanes in metastatic prostate cancer. Can. Res. 77, 5687–5698 (2017).

    Article 
    CAS 

    Google Scholar
     

  • Manjunath, Y. et al. PD-L1 expression with epithelial mesenchymal transition of circulating tumor cells is associated with poor survival in curatively resected non-small cell lung cancer. Cancers 11, 806 (2019).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Mittal, V. Epithelial mesenchymal transition in tumor metastasis. Annu. Rev. Pathol. 13, 395–412 (2018).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Williamson, S. C. et al. Vasculogenic mimicry in small cell lung cancer. Nat. Commun. 7, 1–14 (2016).

    Article 

    Google Scholar
     

  • Lin, P. P. Aneuploid circulating tumor-derived endothelial cell (CTEC): A novel versatile player in tumor neovascularization and cancer metastasis. Cells 9, 1539 (2020).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Dao, L. et al. Prognostic value of cell-surface vimentin-positive CTCs in pediatric sarcomas. Front. Oncol. 11, 760267. doi.org/10.3389/fonc.2021.760267 (2021).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Pantel, K. & Alix-Panabières, C. Circulating tumour cells in cancer patients: Challenges and perspectives. Trends Mol. Med. 16, 398–406 (2010).

    Article 
    PubMed 

    Google Scholar
     

  • Bailey, P. C. & Martin, S. S. Insights on CTC biology and clinical impact emerging from advances in capture technology. Cells. 8(6), 553. doi.org/10.3390/cells8060553 (2019).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Hou, S. et al. Polymer nanofiber-embedded microchips for detection, isolation, and molecular analysis of single circulating melanoma cells. Angew. Chem. 125, 3463–3467 (2013).

    Article 
    ADS 

    Google Scholar
     

  • Aya-Bonilla, C. et al. Immunomagnetic-enriched subpopulations of melanoma circulating tumour cells (CTCs) exhibit distinct transcriptome profiles. Cancers 11, 157 (2019).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Rapanotti, M. C. et al. Stem-mesenchymal signature cell genes detected in heterogeneous circulating melanoma cells correlate with disease stage in melanoma patients. Front. Mol. Biosci. 7, 92 (2020).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Guadagni, S. et al. A pilot study of the predictive potential of chemosensitivity and gene expression assays using circulating tumour cells from patients with recurrent ovarian cancer. Int. J. Mol. Sci. 21, 4813 (2020).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Ferrarini, A. et al. A streamlined workflow for single-cells genome-wide copy-number profiling by low-pass sequencing of LM-PCR whole-genome amplification products. PLoS ONE 13, e0193689 (2018).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Beasley, A. et al. Clinical application of circulating tumor cells and circulating tumor DNA in uveal melanoma. JCO Precis. Oncol. 2, 1–12 (2018).


    Google Scholar
     

  • Asante, D.-B., Calapre, L., Ziman, M., Meniawy, T. M. & Gray, E. S. Liquid biopsy in ovarian cancer using circulating tumor DNA and cells: Ready for prime time?. Cancer Lett. 468, 59–71 (2020).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Asante, D.-B. et al. Multi-marker immunofluorescent staining and PD-L1 detection on circulating tumour cells from ovarian cancer patients. Cancers 13, 6225 (2021).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Kamal, M. et al. Cytopathologic identification of circulating tumor cells (CTCs) in breast cancer: Application of size-based enrichment. Clin. Diagn. Pathol. 4, 1–5 (2019).


    Google Scholar
     

  • Bitting, R. L. et al. Development of a method to isolate circulating tumor cells using mesenchymal-based capture. Methods 64, 129–136 (2013).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Cheng, H. et al. Combined detection and subclass characteristics analysis of CTCs and CTECs by SE-iFISH in ovarian cancer. Chin. J. Cancer Res. 33, 256 (2021).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Zhang, L. et al. PD-L1+ aneuploid circulating tumor endothelial cells (CTECs) exhibit resistance to the checkpoint blockade immunotherapy in advanced NSCLC patients. Cancer Lett. 469, 355–366 (2020).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Network, C. G. A. R. Integrated genomic analyses of ovarian carcinoma. Nature 474, 609 (2011).

    Article 

    Google Scholar
     

  • Kuo, K.-T. et al. Analysis of DNA copy number alterations in ovarian serous tumors identifies new molecular genetic changes in low-grade and high-grade carcinomas. Can. Res. 69, 4036–4042 (2009).

    Article 
    CAS 

    Google Scholar
     

  • Salmon, C. et al. Image-based identification and genomic analysis of single circulating tumor cells in high grade serous ovarian cancer patients. Cancers 13, 3748 (2021).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Riethdorf, S., O’Flaherty, L., Hille, C. & Pantel, K. Clinical applications of the Cell Search platform in cancer patients. Adv. Drug Deliv. Rev. 125, 102–121 (2018).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Schwarz, R. F. et al. Spatial and temporal heterogeneity in high-grade serous ovarian cancer: A phylogenetic analysis. PLoS Med. 12, e1001789 (2015).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Lanuti, P. et al. A standardized flow cytometry network study for the assessment of circulating endothelial cell physiological ranges. Sci. Rep. 8, 1–10 (2018).

    Article 

    Google Scholar
     

  • Liu, Z. et al. CD31-labeled circulating endothelial cells as predictor in anlotinib-treated non-small-cell lung cancer: Analysis on ALTER-0303 study. Cancer Med. 7, 3011–3021 (2018).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Starlinger, P. et al. Discrimination between circulating endothelial cells and blood cell populations with overlapping phenotype reveals distinct regulation and predictive potential in cancer therapy. Neoplasia 13, 980–990 (2011).

    Article 
    CAS 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Nagl, L., Horvath, L., Pircher, A. & Wolf, D. Tumor endothelial cells (TECs) as potential immune directors of the tumor microenvironment–new findings and future perspectives. Front. Cell Dev. Biol. 8, 766 (2020).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Bidard, F.-C. et al. Clinical value of circulating endothelial cells and circulating tumor cells in metastatic breast cancer patients treated first line with bevacizumab and chemotherapy. Ann. Oncol. 21, 1765–1771 (2010).

    Article 
    PubMed 

    Google Scholar
     

  • Rahbari, N. N. et al. Prognostic value of circulating endothelial cells in metastatic colorectal cancer. Oncotarget 8, 37491 (2017).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Po, J. W. et al. Improved ovarian cancer EMT-CTC isolation by immunomagnetic targeting of epithelial EpCAM and mesenchymal N-cadherin. J.Circul. Biomark. 7, 1849454418782617 (2018).

    Article 

    Google Scholar
     

  • Haunschild, C. E. & Tewari, K. S. Bevacizumab use in the frontline, maintenance and recurrent settings for ovarian cancer. Future Oncol. 16, 225–246 (2020).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Pirtea, L., Raica, M. & Cimpean, A. M. Endothelial cell activation and proliferation in ovarian tumors: Two distinct steps as potential markers for antiangiogenic therapy response. Mol. Med. Rep. 5, 1181–1184 (2012).

    CAS 
    PubMed 

    Google Scholar
     

  • Pantel, K. et al. Circulating epithelial cells in patients with benign colon diseases. Clin. Chem. 58, 936–940 (2012).

    Article 
    CAS 
    PubMed 

    Google Scholar
     

  • Jou, H.-J. et al. An automatic platform based on nanostructured microfluidic chip for isolating and identification of circulating tumor cells. Micromachines 12, 473 (2021).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Guo, Y.-X. et al. Diagnostic value of HE4+ circulating tumor cells in patients with suspicious ovarian cancer. Oncotarget 9, 7522 (2018).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Nair, N. et al. Genomic analysis of uterine lavage fluid detects early endometrial cancers and reveals a prevalent landscape of driver mutations in women without histopathologic evidence of cancer: A prospective cross-sectional study. PLoS Med. 13, e1002206 (2016).

    Article 
    PubMed 
    PubMed Central 

    Google Scholar
     

  • Adalsteinsson, V. A. et al. Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors. Nat. Commun. 8, 1–13 (2017).

    Article 
    CAS 

    Google Scholar
     

  • Read more here: Source link